Literature DB >> 16155607

Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Michael D Lairmore1, Lee Silverman, Lee Ratner.   

Abstract

Over the past 25 years, animal models of human T-lymphotropic virus type 1 (HTLV-1) infection and transformation have provided critical knowledge about viral and host factors in adult T-cell leukemia/lymphoma (ATL). The virus consistently infects rabbits, some non-human primates, and to a lesser extent rats. In addition to providing fundamental concepts in viral transmission and immune responses against HTLV-1 infection, these models have provided new information about the role of viral proteins in carcinogenesis. Mice and rats, in particular immunodeficient strains, are useful models to assess immunologic parameters mediating tumor outgrowth and therapeutic invention strategies against lymphoma. Genetically altered mice including both transgenic and knockout mice offer important models to test the role of specific viral and host genes in the development of HTLV-1-associated lymphoma. Novel approaches in genetic manipulation of both HTLV-1 and animal models are available to address the complex questions that remain about viral-mediated mechanisms of cell transformation and disease. Current progress in the understanding of the molecular events of HTLV-1 infection and transformation suggests that answers to these questions are approachable using animal models of HTLV-1-associated lymphoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155607      PMCID: PMC2652704          DOI: 10.1038/sj.onc.1208974

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  177 in total

Review 1.  Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades.

Authors:  Michael L Gatza; Julie C Watt; Susan J Marriott
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

Review 2.  Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.

Authors:  Charles R M Bangham
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

3.  Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.

Authors:  Zhuo Zhang; Meili Zhang; Carolyn K Goldman; Jeffrey V Ravetch; Thomas A Waldmann
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

4.  Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy.

Authors:  Utano Tomaru; Hitoshi Ikeda; Xiuyun Jiang; Osamu Ohya; Takashi Yoshiki
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

5.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Authors:  Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald L Princler; David Derse; Tom Misteli; Genoveffa Franchini
Journal:  Nat Med       Date:  2004-01-18       Impact factor: 53.440

6.  The genetic background as a determinant of human T-cell leukemia virus type 1 proviral load.

Authors:  Takayuki Nitta; Masakazu Tanaka; Binlian Sun; Shuji Hanai; Masanao Miwa
Journal:  Biochem Biophys Res Commun       Date:  2003-09-12       Impact factor: 3.575

7.  High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys.

Authors:  Anne-Sophie Gabet; Antoine Gessain; Eric Wattel
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

Review 8.  Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Christophe Nicot; Julie M Johnson
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

Review 9.  The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.

Authors:  Charles R M Bangham
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

10.  HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.

Authors:  Jianxin Ye; Lee Silverman; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  31 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

3.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Authors:  Valerio W Valeri; Anna Hryniewicz; Vibeke Andresen; Kathy Jones; Claudio Fenizia; Izabela Bialuk; Hye Kyung Chung; Risaku Fukumoto; Robyn Washington Parks; Maria Grazia Ferrari; Christophe Nicot; Valentina Cecchinato; Frank Ruscetti; Genoveffa Franchini
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

4.  Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.

Authors:  Priya Kannian; Han Yin; Rami Doueiri; Michael D Lairmore; Soledad Fernandez; Patrick L Green
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

5.  De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.

Authors:  Paola Miyazato; Jun-ichirou Yasunaga; Yuko Taniguchi; Yoshio Koyanagi; Hiroaki Mitsuya; Masao Matsuoka
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 6.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

7.  Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.

Authors:  Rashade A H Haynes; Bevin Zimmerman; Laurie Millward; Evan Ware; Christopher Premanandan; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

8.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

9.  Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.

Authors:  Masakazu Tanaka; Takayuki Nitta; Binlian Sun; Jun-Ichi Fujisawa; Masanao Miwa
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

10.  Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.

Authors:  C Parrula; B Zimmerman; P Nadella; S Shu; T Rosol; S Fernandez; M Lairmore; S Niewiesk
Journal:  Vet Pathol       Date:  2009-05-09       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.